2026 Global: Bionics Market-Competitive Review (2032) report
Description
The 2026 Global: Bionics Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Leading players in the bionics market include Ossur, headquartered in Reykjavik, Iceland; Ottobock, headquartered in Duderstadt, Germany; Cyberdyne, headquartered in Tsukuba, Japan; Ekso Bionics, headquartered in Richmond, California, United States; and Hanger, Inc., headquartered in Austin, Texas, United States. Ossur offers comprehensive prosthetic and orthotic systems, with advanced sockets, microprocessor knees, and integrated care networks that support patients across life stages. Ottobock provides an extensive line of prosthetic knees, hands, orthoses, and rehabilitation devices, backed by a global service footprint. Cyberdyne develops neurorehabilitation exoskeletons, notably the HAL series, enabling powered gait assistance in clinical and industrial settings. Ekso Bionics focuses on powered exoskeletons for rehabilitation and mobility, including EksoGT and EksoNR, designed for hospital and clinic workflows. Hanger combines prosthetics and orthotics clinics with robotics-enabled therapy and digital tools to personalize devices for diverse functional goals. These brands also pursue ongoing research collaborations, clinical trials, and training programs to advance usability and safety.
Other players shaping the market include ReWalk Robotics, headquartered in Tel Aviv, Israel; Rex Bionics, headquartered in Auckland, New Zealand; Bionik Laboratories Corp., headquartered in Montreal, Canada; Bioservo Technologies AB, headquartered in Stockholm, Sweden; and Steeper Group, headquartered in Cambridge, United Kingdom. ReWalk markets exoskeletons for personal mobility and rehabilitation. Rex Bionics develops sit-to-stand and gait-support exoskeletons for home and clinical use. Bionik Laboratories focuses on neuromodulation-driven rehabilitation devices and robotic assistive technologies for upper and lower limbs. Bioservo brings soft-robotics grip enhancements to bionics, with products like the IronHand system that augment grip strength. Steeper Group provides prosthetic and orthotic components, rehabilitation aids, and research collaborations to support patient care and device development. These companies emphasize interoperability, cloud-connected devices, and data-driven outcomes to optimize therapy and daily living for users. Their portfolios increasingly blend hardware with software platforms that track metrics such as gait symmetry, dexterity, and device utilization.
Together these ten companies illustrate the breadth of the bionics market, spanning prosthetics, orthotics, exoskeletons, and neurorehabilitation. They pursue innovations in sensors, control interfaces, efficiency, and data analytics to improve mobility, independence, and quality of life for people with limb loss or motor impairment. Market dynamics—aging populations, rising rehab demand, and the expansion of home-based therapy—drive investment in research and regulatory advancement. Global collaborations with clinics, universities, and regulatory bodies help validate safety and efficacy, enabling broader reimbursement and adoption. As the field evolves, the line between assistive devices and augmentation technologies continues to blur, challenging manufacturers to balance safety, usability, and affordability while translating laboratory breakthroughs into real-world outcomes for patients worldwide. This dynamic fosters cross-disciplinary collaboration among engineers, clinicians, payers, and patients. Continued cross-sector partnerships will be essential to scale manufacturing, reduce costs, and improve accessibility for diverse patient populations worldwide across hospitals and homes.
Leading players in the bionics market include Ossur, headquartered in Reykjavik, Iceland; Ottobock, headquartered in Duderstadt, Germany; Cyberdyne, headquartered in Tsukuba, Japan; Ekso Bionics, headquartered in Richmond, California, United States; and Hanger, Inc., headquartered in Austin, Texas, United States. Ossur offers comprehensive prosthetic and orthotic systems, with advanced sockets, microprocessor knees, and integrated care networks that support patients across life stages. Ottobock provides an extensive line of prosthetic knees, hands, orthoses, and rehabilitation devices, backed by a global service footprint. Cyberdyne develops neurorehabilitation exoskeletons, notably the HAL series, enabling powered gait assistance in clinical and industrial settings. Ekso Bionics focuses on powered exoskeletons for rehabilitation and mobility, including EksoGT and EksoNR, designed for hospital and clinic workflows. Hanger combines prosthetics and orthotics clinics with robotics-enabled therapy and digital tools to personalize devices for diverse functional goals. These brands also pursue ongoing research collaborations, clinical trials, and training programs to advance usability and safety.
Other players shaping the market include ReWalk Robotics, headquartered in Tel Aviv, Israel; Rex Bionics, headquartered in Auckland, New Zealand; Bionik Laboratories Corp., headquartered in Montreal, Canada; Bioservo Technologies AB, headquartered in Stockholm, Sweden; and Steeper Group, headquartered in Cambridge, United Kingdom. ReWalk markets exoskeletons for personal mobility and rehabilitation. Rex Bionics develops sit-to-stand and gait-support exoskeletons for home and clinical use. Bionik Laboratories focuses on neuromodulation-driven rehabilitation devices and robotic assistive technologies for upper and lower limbs. Bioservo brings soft-robotics grip enhancements to bionics, with products like the IronHand system that augment grip strength. Steeper Group provides prosthetic and orthotic components, rehabilitation aids, and research collaborations to support patient care and device development. These companies emphasize interoperability, cloud-connected devices, and data-driven outcomes to optimize therapy and daily living for users. Their portfolios increasingly blend hardware with software platforms that track metrics such as gait symmetry, dexterity, and device utilization.
Together these ten companies illustrate the breadth of the bionics market, spanning prosthetics, orthotics, exoskeletons, and neurorehabilitation. They pursue innovations in sensors, control interfaces, efficiency, and data analytics to improve mobility, independence, and quality of life for people with limb loss or motor impairment. Market dynamics—aging populations, rising rehab demand, and the expansion of home-based therapy—drive investment in research and regulatory advancement. Global collaborations with clinics, universities, and regulatory bodies help validate safety and efficacy, enabling broader reimbursement and adoption. As the field evolves, the line between assistive devices and augmentation technologies continues to blur, challenging manufacturers to balance safety, usability, and affordability while translating laboratory breakthroughs into real-world outcomes for patients worldwide. This dynamic fosters cross-disciplinary collaboration among engineers, clinicians, payers, and patients. Continued cross-sector partnerships will be essential to scale manufacturing, reduce costs, and improve accessibility for diverse patient populations worldwide across hospitals and homes.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
